Stratview Research has published a new report titled “Clinical Microbiology Market” which is segmented by Product Type (Instruments [Laboratory Instruments and Microbiology Analyzers] and Reagents [Pathogen-specific Kits and General Reagents]), by Disease Type (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Other Diseases), by End-User Type (Hospitals & Diagnostic Centers, Custom Lab Service Providers, and Academic & Research Institutes), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
As per the study, the market was estimated to grow from USD 3.96 Billion in 2021 to USD 6.18 Billion by 2028 at a CAGR of 6.52% during the forecast period of 2022-2028.
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis –
The Instruments Product type segment is expected to account for the larger share of the market during the forecast period of 2022-28.
The market is segmented as instruments and reagents. This segment is driving the market due to technological advancements in molecular techniques and the proteomics field, as well as the widespread adoption of conventional laboratory instruments among researchers and academia.
The Hospitals & Diagnostic Centers segment is expected to hold the largest share of the market during the forecast period of 2022-28.
The market is segmented as hospitals & diagnostic centers, custom lab service providers, and academic & research institutes. This segment is driving the market due to the growing awareness among doctors about the benefits offered by molecular diagnostics products, ongoing expansion of healthcare infrastructures across emerging economies, rising incidence of diseases such as HIV-AIDS, malaria, tuberculosis, and epidemic diseases, and the availability of technologically advanced products for the diagnosis of infectious diseases.
Which Region is expected to remain the largest market?
North America is expected to be the leading region in the market over the forecast period of 2022-28.
This segment is driving the market due to high adoption of advanced diagnostic technologies, favorable government regulations, and the presence of well-established distribution channels for clinical microbiology product manufacturers and suppliers, all of which are fueling the regional market growth. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
Who are the Key Players in the Market?
This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Clinical Microbiology Market:
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Danaher Corporation
- Hologic, Inc.
- Neogen Corporation
- The 3M Company.
- The Merck Group
Key questions answered by the report:
- What is the projected CAGR for revenue from the Clinical Microbiology Market during the forecast period?
- What would be the market be valued at by 2028?
- What is a major driving factor for growth of the market?
- Which region accounted for largest revenue share in the Clinical Microbiology Market?
- Which are the major market players?
Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to firstname.lastname@example.org. Or connect with our experts at +1-313-307-4176.
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.